Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly …
Over the last 12 months, insiders at Perspective Therapeutics, Inc. have bought $58.43M and sold $0 worth of Perspective Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Perspective Therapeutics, Inc. have bought $58.43M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lantheus Alpha Therapy, LLC (10 percent owner) — $57.41M. Williamson Robert F III (director) — $333,390. Spoor Johan M. (CEO) — $248,030.
The last purchase of 8,000 shares for transaction amount of $30,132 was made by Spoor Johan M. (CEO) on 2024‑12‑04.
2024-12-04 | CEO | 8,000 0.0119% | $3.77 | $30,132 | -6.20% | |||
2024-12-04 | director | 25,975 0.0396% | $3.85 | $100,004 | -6.20% | |||
2024-11-25 | director | 6,266 0.0078% | $3.64 | $22,814 | +0.68% | |||
2024-11-25 | CEO | 26,500 0.0342% | $3.79 | $100,468 | +0.68% | |||
2024-11-25 | Chief Financial Officer | 12,829 0.0167% | $3.82 | $48,974 | +0.68% | |||
2024-06-17 | Chief Financial Officer | 1,800 0.006% | $9.81 | $17,667 | +18.42% | |||
2024-06-14 | director | 4,587 0.017% | $10.90 | $49,990 | +14.30% | |||
2024-06-13 | CEO | 100,000 0.0399% | $1.17 | $117,430 | +5.39% | |||
2024-06-03 | director | 34,246 0.017% | $1.46 | $49,992 | -10.44% | |||
2024-05-31 | director | 55,000 0.0258% | $1.38 | $75,900 | -11.01% | |||
2024-05-31 | Chief Financial Officer | 25,006 0.0119% | $1.40 | $35,007 | -11.01% | |||
2024-05-29 | director | 30,031 0.0136% | $1.33 | $40,014 | -8.96% | |||
2024-03-06 | 10 percent owner | 60.43M 19.5267% | $0.95 | $57.41M | +24.02% | |||
2024-01-30 | director | 127,206 0.0309% | $0.71 | $90,710 | +64.51% | |||
2024-01-29 | director | 25,266 0.0055% | $0.64 | $16,170 | +83.63% | |||
2024-01-26 | director | 110,613 0.0212% | $0.56 | $62,304 | +97.44% | |||
2024-01-25 | director | 22,134 0.0037% | $0.49 | $10,846 | +140.08% | |||
2024-01-24 | Chief Medical Officer | 280,000 0.0476% | $0.50 | $139,888 | +152.35% | |||
2024-01-24 | director | 29,862 0.005% | $0.49 | $14,632 | +152.35% |